{"id":"doi:10.1158/1055-9965.epi-19-0221","kind":"review","title":"Cancer Progress and Priorities: Lung Cancer","authors":["Matthew B. Schabath","Michele L. Coté"],"author_count":2,"year":2019,"published":"2019-10-01","venue":"Cancer Epidemiology Biomarkers & Prevention","cited_by":1173,"doi":"10.1158/1055-9965.epi-19-0221","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1158/1055-9965.epi-19-0221","archive_url":"https://space-kitty.com/papers/doi:10.1158/1055-9965.epi-19-0221","updated":null,"pmid":"31575553","pmcid":null,"openalex_id":"W2979026278","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"peer_reviewed":null,"categories":["Lung Cancer Diagnosis and Treatment"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}